Spike RBD
|
SPD-M415
|
Human |
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AS113) (Omicron Specific)
|
HEK293 |
|
|
|
|
Spike RBD
|
SPD-M265
|
Human |
Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (MALS verified)
|
HEK293 |
|
|
|
|
Spike RBD
|
SPD-Y170
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (5C5C10) (BQ.1.1/Omicron Specific)
|
Hybridoma |
|
|
|
|
Spike RBD
|
SPD-Y171
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (5F8E1) (XBB.1.5/Omicron Specific)
|
Hybridoma |
|
|
|
|
Spike RBD
|
SPD-S298
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (9A6A11) (XBB.1.5/Omicron Specific) (MALS verified)
|
HEK293 |
|
|
|
|
Spike RBD
|
SPD-S299
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (5C5C10) (BQ.1.1/Omicron Specific) (MALS verified)
|
HEK293 |
|
|
|
|
Spike RBD
|
SPD-Y168
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (9A6A11) (XBB.1.5/Omicron Specific)
|
Hybridoma |
|
|
|
|
Spike RBD
|
SPD-M541
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (10B1A5) (BA.2&BA.4&BA.5/Omicron Specific) (MALS verified)
|
HEK293 |
|
|
|
|
Spike RBD
|
SPD-PLS298
|
Mouse |
HRP-Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (9A6A11) (XBB.1.5/Omicron Specific)
|
HEK293 |
|
|
|
|
Spike RBD
|
SPD-M305
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (AS113) (Omicron Specific)
|
HEK293 |
|
|
|
|
Spike RBD
|
S1N-M130
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM130)
|
HEK293 |
|
|
|
|
Spike RBD
|
S1N-M122
|
Mouse |
Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM122)
|
HEK293 |
|
|
|
|
Spike RBD
|
SPD-C73
|
Rabbit |
Anti-SARS-CoV-2 Omicron Antibody-3A7C12, Rabbit IgG
|
Rabbit |
|
|
|
|
Spike protein
|
SPN-Y169
|
Mouse |
Anti-SARS-CoV-2 Spike Antibody, Mouse IgG1 (2C9C9) (XBB.1.5/Omicron Specific)
|
Hybridoma |
|
|
|
|
Spike protein
|
SPN-M551
|
Mouse |
Anti-SARS-CoV-2 Spike Antibody, Human IgG1 (9A5E10) (BA.4&BA.5/Omicron Specific) (MALS verified)
|
HEK293 |
|
|
|
|